latest news.

Cosette Pharmaceuticals Launches Clomid® Tabs

Launch Ensures the Continued Availability of a Trusted Product with Decades of Experience by Patients and Prescribers.


Together, everyone at Cosette contributes to a culture that fosters innovation, celebrates collaboration and recognizes excellence. We are perpetually pursuing the highest quality standards, the most efficient supply chain and innovating every day in everything we do.


Our highly experienced leadership team is busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage our expertise, efficiency, and infrastructure to create remarkable new opportunities.


While staying true to our proud therapeutic history of dermatology products, suppositories, and oral liquids, we’re busy expanding our offerings – through strategic partnerships and internal R&D. Our focus on innovation and supply reliability is the foundation of our rapidly diversifying portfolio.


Metronidazole Vaginal Gel

Cosette Pharmaceuticals Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal® 0.75%

Cosette Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has…

Read More

EY Announces Apurva Saraf, President and CEO of Cosette Pharmaceuticals as an Entrepreneur Of The Year® 2023 New Jersey Award Winner

Ernst & Young LLP (EY US) today announced that Apurva Saraf, President and CEO of Cosette…

Read More

Cosette Pharmaceuticals Acquires Intrarosa® from Endoceutics, Inc.

Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial…

Read More